Your browser doesn't support javascript.
loading
Dynamics of SARS-CoV-2 seroprevalence during the first year of the COVID-19 pandemic in the Northeast region of Brazil.
de Souza Araújo, Adriano Antunes; Quintans-Júnior, Lucindo José; Heimfarth, Luana; Schimieguel, Dulce Marta; Corrêa, Cristiane Bani; de Moura, Tatiana Rodrigues; Cavalcante, Rafael Ciro Marques; Grespan, Renata; de Souza Siqueira Quintans, Jullyana; Dos Santos, Danillo Menezes; da Silva, Danilo Nobre; de Oliveira, Yrna Lorena Matos; de Franca, Mariana Nobre Farias; da Conceição Silva, Marcílio; de Sá, Darla Lorena Freitas; de Carvalho, Fernanda Oliveira; de Souza, Mércia Feitosa; de Oliveira Góes, Marco Aurélio; Santos, Victor Santana; Martins-Filho, Paulo Ricardo.
Afiliação
  • de Souza Araújo AA; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil.
  • Quintans-Júnior LJ; Health Sciences Graduate Program, Federal University of Sergipe, Aracaju, Sergipe, Brazil.
  • Heimfarth L; Graduate Program in Pharmaceutical Sciences, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil.
  • Schimieguel DM; Health Sciences Graduate Program, Federal University of Sergipe, Aracaju, Sergipe, Brazil.
  • Corrêa CB; Graduate Program in Pharmaceutical Sciences, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil.
  • de Moura TR; Department of Physiology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil.
  • Cavalcante RCM; Health Sciences Graduate Program, Federal University of Sergipe, Aracaju, Sergipe, Brazil.
  • Grespan R; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil.
  • de Souza Siqueira Quintans J; Graduate Program in Pharmaceutical Sciences, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil.
  • Dos Santos DM; Health Sciences Graduate Program, Federal University of Sergipe, Aracaju, Sergipe, Brazil.
  • da Silva DN; Department of Morphology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil.
  • de Oliveira YLM; Health Sciences Graduate Program, Federal University of Sergipe, Aracaju, Sergipe, Brazil.
  • de Franca MNF; Department of Morphology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil.
  • da Conceição Silva M; Department of Pharmacy, Federal University of Sergipe, Lagarto, Sergipe, Brazil.
  • de Sá DLF; Department of Physiology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil.
  • de Carvalho FO; Graduate Program in Physiological Sciences, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil.
  • de Souza MF; Health Sciences Graduate Program, Federal University of Sergipe, Aracaju, Sergipe, Brazil.
  • de Oliveira Góes MA; Department of Physiology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil.
  • Santos VS; Health Sciences Graduate Program, Federal University of Sergipe, Aracaju, Sergipe, Brazil.
  • Martins-Filho PR; Health Sciences Graduate Program, Federal University of Sergipe, Aracaju, Sergipe, Brazil.
Pathog Glob Health ; 117(5): 505-512, 2023 07.
Article em En | MEDLINE | ID: mdl-36094065
ABSTRACT
In this household-based seroepidemiological survey, we analyzed the dynamics of SARS-CoV-2 seroprevalence during the first year of the COVID-19 pandemic in Sergipe State, Northeast Brazil, the poorest region of the country. A total of 16,547 individuals were tested using a rapid IgM-IgG antibody test and fluorescence immunoassay (FIA). Seroprevalence rates were presented according to age, sex, and geographic region. A comparative analysis was performed between the results obtained in July 2020 (peak of the first wave), August - November 2020 (end of the first wave), and February - March 2021 (beginning of the second wave). Seroprevalence rates in the three phases were estimated at 9.3% (95% CI 8.5-10.1), 12.0% (95% CI 11.2-12.9) and 15.4% (95% CI 14.5-16.4). At the end of the first wave, there was a rise in seroprevalence in the countryside (p < 0.001). At the beginning of the second wave, we found an increase in seroprevalence among women (p < 0.001), adults aged 20 to 59 years (p < 0.001), and the elderly (p < 0.001). In this phase, we found an increase in estimates both in metropolitan areas and in the countryside (p < 0.001). This study showed an increase in SARS-CoV-2 seroprevalence over the first year of the pandemic, with approximately one in six people having anti-SARS-CoV-2 antibodies at the beginning of the second wave of COVID-19. Furthermore, our results suggest a rapid spread of COVID-19 from metropolitan areas to the countryside during the first months of the pandemic.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article